
Vriptan M 500mg/20mg Tablet SR
Marketer
Zylig Lifesciences
Salt Composition
Metformin (500mg) + Teneligliptin (20mg)
Overview Vriptan M 500mg/20mg Tablet SR
Combiflex DM 500mg/20mg Extended-Release Tablets combine two active ingredients to manage elevated blood glucose in patients with type 2 diabetes. This dual action helps mitigate serious diabetic complications like renal impairment and vision loss, potentially lowering the risk of cardiovascular events. Combiflex DM may be used independently or in conjunction with other antidiabetic therapies. Optimal effectiveness requires adherence to a balanced diet and consistent exercise. Dosage is personalized based on individual health status, blood sugar readings, and concurrent medications. Consuming it with food minimizes gastrointestinal discomfort. Consistent daily dosing, at the same time each day, maximizes therapeutic benefits; discontinuation should only occur under medical supervision. Effective blood sugar control reduces the risk of future complications. Maintaining the prescribed diet and exercise regimen is crucial. Lifestyle choices are integral to successful diabetes management. Common side effects include nausea, vomiting, diarrhea, stomach upset, and headache. Hypoglycemia is a potential adverse effect, particularly when used with insulin or sulfonylureas; proper recognition and management of low blood sugar is essential. This medication is not universally suitable. Prior to commencing treatment, inform your physician of any history of kidney, liver, or heart disease, pancreatic disorders, or significant alcohol consumption. Pregnant or lactating individuals should seek medical counsel before use. Interactions with other medications are possible; provide your doctor with a complete medication list to ensure safety. Alcohol should be limited due to its potential to decrease blood glucose levels. Your doctor will monitor renal function and blood glucose levels throughout treatment.
Primary Ingredients of Vriptan M 500mg/20mg Tablet SR
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Vriptan M 500mg/20mg Tablet SR
Managing type 2 diabetes
Major Benefits of Vriptan M 500mg/20mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Vriptan M 500mg/20mg Extended-Release Tablets should be administered with a meal.
Common Side effects of Vriptan M 500mg/20mg Tablet SR:
- Nausea
- Vomiting
- Headache
- Hypoglycemia (low blood glucose level)
- Diarrhea
How to use Vriptan M 500mg/20mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Vriptan M 500mg/20mg Extended-Release Tablet with food.
How Vriptan M 500mg/20mg Tablet SR works:
Each tablet of Vriptan M 500mg/20mg SR contains a dual antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Vriptan M 500mg/20mg SR tablets with alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The extended-release combination tablet Vriptan M 500mg/20mg might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Vriptan M 500mg/20mg tablets are likely unsuitable for breastfeeding mothers. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Vriptan M 500mg/20mg Tablet SR on driving ability is undetermined. Refrain from driving if symptoms impair concentration or reaction time.
KidneyCAUTION
Exercise caution when administering Vriptan M 500mg/20mg SR tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Avoid prescribing Vriptan M 500mg/20mg SR tablets to patients exhibiting severe kidney disease. Close monitoring of kidney function is recommended throughout the treatment period.
LiverUNSAFE
The use of Vriptan M 500mg/20mg SR tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.
What if you forget to take Vriptan M 500mg/20mg Tablet SR :
Should you forget a dose of Vriptan M 500mg/20mg Tablet SR, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Vriptan M 500mg/20mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
